Skip to main content
. 2017 Mar 1;22(4):293–300. doi: 10.1111/nep.12891

Figure 3.

Figure 3

Mean daily number of tablets for daily dose of PA21 (sucroferric oxyhydroxide) and sevelamer (per protocol set). The mean number of tablets for daily dose of PA21 was notably lower than that of sevelamer.